2型糖尿病无法解释老年人运动能力或骨骼肌功能的种族差异
该研究基于英国SABRE队列708名老年人,比较南亚裔、加勒比非洲裔与欧洲裔的运动能力、肌力和骨骼肌灌注及氧化能力。结果显示南亚裔和加勒比非洲裔运动能力低于欧洲裔,南亚裔肌力和肌肉灌注/氧化能力更差,这些差异在调整2型糖尿病或HbA1c后仍存在。
要点
- 南亚裔和加勒比非洲裔老年人运动能力低于欧洲裔,调整2型糖尿病后差异仍存在。
- 南亚裔肌力较低、肌肉灌注和氧化能力较差,加勒比非洲裔肌力较高。
- 南亚裔肌肉氧消耗恢复时间常数τ在调整所有混杂因素后仍显著延长。
核心结论
- 南亚裔和加勒比非洲裔老年人运动能力降低不能由2型糖尿病患病率较高解释。
- 南亚裔肌肉功能灌注和氧化能力较差,可能贡献英国少数族裔老年人更高疾病负担。
研究设计与样本
- 基于英国SABRE人群队列,纳入708名老年人(平均年龄73±7岁,56%男性),包括欧洲裔311人、南亚裔232人、加勒比非洲裔165人。
- 采用6分钟踏步试验测运动能力(含氧耗)和握力,近红外光谱测肌肉组织饱和指数变化和氧化能力(时间常数τ),用多元线性回归分析。
主要发现
- 调整年龄和性别后,南亚裔和加勒比非洲裔氧耗较欧洲裔降低(β=-1.2 ml min-1 kg-1,95%CI -1.9~-0.4,p=0.002;β=-1.7 ml min-1 kg-1,95%CI -2.5~-0.8,p<0.001)。
- 南亚裔握力较欧洲裔低(β=-9 kPa,95%CI -12~-6,p<0.001),加勒比非洲裔握力较高(β=6 kPa,95%CI 3~9,p<0.001)。
- 南亚裔较欧洲裔∆TSI%下降更大(β=-0.9%,95%CI -1.7~-0.1,p=0.024),τ更长(β=11 s,95%CI 3~18,p=0.006)。
- 调整2型糖尿病或HbA1c(握力另调去脂体重)后,氧耗和握力的种族差异仍存在。
- 调整体力活动、腰臀比、心血管疾病或高血压、吸烟、血红蛋白或β受体阻滞剂后,欧洲裔与南亚裔差异不再显著;但τ在所有混杂因素调整后仍显著延长。
临床怎么用
- 评估老年南亚裔和加勒比非洲裔运动耐量时,不能仅以2型糖尿病解释其功能下降。
- 对南亚裔老年人应关注骨骼肌灌注和氧化能力受损,考虑针对性运动干预。
局限性
- 原文摘要未报告研究局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
AIMS/HYPOTHESIS: The aim of this study was to compare exercise capacity, strength and skeletal muscle perfusion during exercise, and oxidative capacity between South Asians, African Caribbeans and Europeans, and determine what effect ethnic differences in the prevalence of type 2 diabetes has on these functional outcomes. METHODS: In total, 708 participants (aged [mean±SD] 73 ± 7 years, 56% male) were recruited from the Southall and Brent Revisited (SABRE) study, a UK population-based cohort comprised of Europeans (n = 311) and South Asian (n = 232) and African Caribbean (n = 165) migrants. Measurements of exercise capacity using a 6 min stepper test (6MST), including measurement of oxygen consumption ([Formula: see text]) and grip strength, were performed. Skeletal muscle was assessed using near infrared spectroscopy (NIRS); measures included changes in tissue saturation index (∆TSI%) with exercise and oxidative capacity (muscle oxygen consumption recovery, represented by a time constant [τ]). Analysis was by multiple linear regression. RESULTS: When adjusted for age and sex, in South Asians and African Caribbeans, exercise capacity was reduced compared with Europeans ([Formula: see text] [ml min-1 kg-1]: β = -1.2 [95% CI -1.9, -0.4], p = 0.002, and β -1.7 [95% CI -2.5, -0.8], p < 0.001, respectively). South Asians had lower and African Caribbeans had higher strength compared with Europeans (strength [kPa]: β = -9 [95% CI -12, -6), p < 0.001, and β = 6 [95% CI 3, 9], p < 0.001, respectively). South Asians had greater decreases in TSI% and longer τ compared with Europeans (∆TSI% [%]: β = -0.9 [95% CI -1.7, -0.1), p = 0.024; τ [s]: β = 11 [95% CI 3, 18], p = 0.006). Ethnic differences in [Formula: see text] and grip strength remained despite adjustment for type 2 diabetes or HbA1c (and fat-free mass for grip strength). However, the differences between Europeans and South Asians were no longer statistically significant after adjustment for other possible mediators or confounders (including physical activity, waist-to-hip ratio, cardiovascular disease or hypertension, smoking, haemoglobin levels or β-blocker use). The difference in ∆TSI% between Europeans and South Asians was marginally attenuated after adjustment for type 2 diabetes or HbA1c and was also no longer statistically significant after adjusting for other confounders; however, τ remained significantly longer in South Asians vs Europeans despite adjustment for all confounders. CONCLUSIONS/INTERPRETATION: Reduced exercise capacity in South Asians and African Caribbeans is unexplained by higher rates of type 2 diabetes. Poorer exercise tolerance in these populations, and impaired muscle function and perfusion in South Asians, may contribute to the higher morbidity burden of UK ethnic minority groups in older age.
引用
- Jones S, Tillin T, Williams S, et al. Type 2 diabetes does not account for ethnic differences in exercise capacity or skeletal muscle function in older adults. Diabetologia. 2019. PMID: 31820039. doi:10.1007/s00125-019-05055-w
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。